// App-Quantinova.ai

: 11c-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18f-FDG PET/CT and Prognostic Value Evaluation

Researchers

Presenter

  • María Isabel Morales-Lozano

Principal Investigators

  • Lidia Sancho Rodriguez

  • Ana Alfonso-Pierola

  • Jorge M Nuñez-Cordoba

  • Elena Prieto Azcárate

  • Luis Esteban Tamariz-Amador

  • Juan J Rosales Castillo

  • Maria Luisa Palacios-Berraquero

  • Fernando Guillen Valderrama

  • Andrea Manubens Guarch

  • Angela Bronte Viedma

  • Sofía Huerga Domínguez

  • Victoria Betech Antar

  • Maria Panizo Inogés

  • Felipe Prosper

  • Ramon Lecumberri

  • Jesus San-Miguel

  • Paula Rodriguez Otero

  • María José García Velloso

Medical Centers

  • Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain

  • Clinica Universitaria de Navarra, Navarra, Spain

  • Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • 18F-fluorodeoxyglucose

  • Total lesion glycolysis

Drug/Treatment

  • methionine

  • Fludeoxyglucose (18F)

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved